Excellent
Mostly Aligned
Patient Risk:
Low
Summary
The AI-generated claim matches multiple FDA label statements directing use only for proven or strongly suspected susceptible bacterial infections and links inappropriate use to increased development of drug-resistant bacteria.
Category Scores
Accurate Statements
Penicillin G Potassium Injection should be used only when treating/preventing infections that are proven or strongly suspected to be caused by bacteria.
SECTION 1 — INDICATIONS AND USAGE: “should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.”
This approach is intended to reduce the development of drug-resistant bacteria.
SECTION 1 — INDICATIONS AND USAGE: “To reduce the development of drug-resistant bacteria… should be used only…” and SECTION 5 — PRECAUTIONS (General): prescribing in the absence of proven/strongly suspected bacterial infection is unlikely to provide benefit and increases risk of drug-resistant bacteria.
The label discourages prescribing in the absence of a proven or strongly suspected bacterial infection or prophylactic indication because it increases risk of drug-resistant bacteria.
SECTION 5 — PRECAUTIONS (General): “Prescribing Penicillin G Potassium Injection, USP in the absence of a proven or strongly suspected bacterial infection or a prophylactic indication is unlikely to provide benefit… and increases the risk of the development of drug-resistant bacteria.”
Unsupported Statements
Contradictions
Important Omissions
The response did not explicitly cite the label’s additional context about considering culture/susceptibility information when available (or using local epidemiology/susceptibility patterns for empiric selection).
Importance:
Low
Safety Assessment
Potential Patient Risk:
Low
The statement reflects label language about appropriate antibacterial use to reduce drug resistance; no contradictory or unsafe directions were introduced.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Suggested Improvement
If expanding, include the label’s direction to consider culture/susceptibility data when available and to use local epidemiology/susceptibility patterns for empiric selection.